Empleos de Biotecnología Industrial en auge en USA

Las compañías de biocombustibles y de biotecnología industrial en California han aumentado su número de trabajadores en un 632% (seiscientos treinta y dos por ciento) en los últimos 5 años. Así lo revela un estudio realizado por las dos industrias biotecnológicas más grandes de este estado. Este hecho es especialmente meritorio considerando el actual contexto económico de Estados Unidos. Por esto organizaciones de comercio biotecnológicas de California piden a las autoridades nuevos incentivos para fortalecer este sector y evitar que muchas empresas abandonen el estado.

En general podemos notar que esta es otra noticia que muestra el fuerte crecimiento de las empresas biotecnológicas en Estados Unidos y que concuerda con las predicciones de los analistas. La biotecnología es una herramienta tan poderosa y que se desarrolla tan rápidamente que es, a mi juicio, imposible pensar que no va a incidir fuertemente en la mayoría de las industrias de Chile y del mundo.

Agradecimientos a prof. Eduardo Agosín por compartir esta noticia.

Puedes leer el artículo completo de San Fransisco Business Times a continuación.

Industrial biotech jobs soar, sector asks for policy help

 

California biofuels companies and others in the “industrial biotechnology” sector increased employment by 632 percent over the past five years, according to a survey conducted by the state’s two largest biotech industry associations.

The boom comes from a low starting base — among the 33 companies responding to the survey, 18 had no employees in 2006 — but it highlights the state’s opportunity to capture large-scale biofuel, green industrial chemical and biomaterial production facilities as the industry develops, backers said.

BayBio, Northern California’s biotech trade organization, and BIOCOM, its Southern California counterpart, used the job growth identified in the survey to call on policy makers to consider tax credits or other incentives, such as job-training initiatives, to keep innovation developed in California from translating into production jobs elsewhere.

“It is important for California’s policy makers and educational institutions to be aware of the challenges and opportunities facing these emerging companies in order to bolster the strength of California’s biotechnology industry and help bring innovative, environmentally advantageous products to market,” said BayBio President and CEO Gail Maderis.

Bay Area industrial biotech companies include Emeryville-based Amyris Biotechnologies Inc . (NASDAQ: AMRS), which is producing sugar cane-based fuels in Brazil, as well as Palo Alto enzyme developer Genencor and biofuels company LS9 of South San Francisco.

According to the survey, 15 companies that had at least one employee in 2006 reported an aggregate work force increase of 75 percent. The 18 companies with no employees five years ago now reported a total of 3,254 jobs.

But the survey also said that while 78 percent of respondents have corporate headquarters in California, only 40 percent intend to remain in the state. (The remainder said they were not sure about their plans or did not respond to that survey question.)

What’s more, 45 percent of the respondents have pilot production facilities in California, but only 20 percent said they expect to maintain pilot plants in the state.

Plus, only 20 percent have large commercial production facilities in California, while 45 percent have plants outside the state, mostly due to incentives from those states, regulations in California, high taxes or high salaries.

“The R&D side of this sector is doing well,” BayBio spokesman Travis Blaschek-Miller said, “but the state is lacking pilot and commercial operations — those good-paying jobs and construction jobs that come with those facilities.”

None of the survey’s respondents complained about a lack of available talent in California, perhaps in part because they are able to hire people with experience at traditional biotech drug operations like Bayer HealthCare Pharmaceuticals or Genentech Inc.

“The talent is here,” Blaschek-Miller said.

Fuente: San Fransisco Business Times